-
1 Comment
Hualan Biological Engineering Inc is currently in a long term downtrend where the price is trading 17.5% below its 200 day moving average.
From a valuation standpoint, the stock is 51.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 14.6.
Hualan Biological Engineering Inc's total revenue rose by 83.7% to $2B since the same quarter in the previous year.
Its net income has increased by 103.0% to $649M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.4% to $616M since the same quarter in the previous year.
Based on the above factors, Hualan Biological Engineering Inc gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000001JN8 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 29B |
|---|---|
| Beta | 0.38 |
| Target Price | 19.0014 |
| Dividend Yield | 4.3% |
| PE Ratio | 24.88 |
Hualan Biological Engineering Inc. researches, develops, produces, and commercializes blood products, vaccines, and genetic engineering products in China and internationally. The company offers human serum albumin to treat blood loss trauma, shock caused by burns, intracranial pressure and persistent, liver cirrhosis, and kidney disease; edema for hypoproteinemia, neonatal hyperbilirubinemia, cardiopulmonary bypass, adjuvant treatment of burns, hemodialysis, and human respiratory distress syndrome; intravenous human immunoglobulin (pH4) for immunoglobulin deficiency and autoimmune diseases; and human immunoglobulin to prevent measles and infectious hepatitis. It also provides hepatitis b human immunoglobulin to prevent hepatitis; immunoglobulin for rabies patients; human tetanus immune globulin for tetanus; human coagulation factor blood for bleeding symptoms; human prothrombin complex for congenital and acquired coagulation factor II, VH, IX, X deficiency, overdose of anticoagulants, vitamin k deficiency, bleeding, and hemophilia; and human fibrinogen for congenital fibrinogen reduction, and liver damage and cirrhosis, disseminated intravascular coagulation, postpartum hemorrhage, and coagulation disorders. In addition, the company offers human fibrin glue to treat local; freeze-dried human thrombin for bleeding from abdominal incision wounds; influenza virus split vaccine to prevent influenza; influenza A (H1N1) split vaccine for the prevention of influenza epidemics; ACYW135 group meningococcal polysaccharide vaccine to prevent epidemic cerebrospinal; recombinant hepatitis B vaccine for hepatitis B; Group A and C meningococcal polysaccharide vaccines to prevent epidemics; quadrivalent influenza virus split vaccine for influenza; freeze-dried human rabies vaccine to prevent rabies; adsorbed tetanus vaccine to prevent tetanus. Hualan Biological Engineering Inc. was founded in 1992 and is headquartered in Xinxiang City, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002007.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
